מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

METHYLPHENIDATE HYDROCHLORIDE 30 MG

Verfügbar ab:

MEDILINE LTD.

ATC-Code:

N06BA04

Darreichungsform:

MODIFIED RELEASE CAPSULES

Verabreichungsweg:

PER OS

Hergestellt von:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Therapiegruppe:

METHYLPHENIDATE

Anwendungsgebiete:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient.Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Berechtigungsdatum:

2011-05-01